Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-05-31

FDA Approved: AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM — Supplemental Application (Dr. Reddy's Laboratories Inc)

View source ↗

Summary

FDA supplemental approval for a generic fixed-dose combination of amlodipine besylate and atorvastatin calcium by Dr. Reddy's Laboratories Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine Besylate and Atorvastatin Calcium (amlodipine besylate and atorvastatin calcium)

Snippet

SUPPL AP for AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM (AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM)